| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000027791 |
| Receipt No. | R000031843 |
| Scientific Title | A study for the effects of ingestion of yogurt in adults with discomfort of eyes and nose :A randomized, double-blind, placebo controlled trial |
| Date of disclosure of the study information | 2018/12/23 |
| Last modified on | 2019/11/27 (Ver. 4) |
| Basic information | ||
| Public title | A study for the effects of ingestion of
yogurt in adults with discomfort of eyes and nose :A randomized, double-blind, placebo controlled trial |
|
| Acronym | A study for the effects of ingestion of
yogurt in adults with discomfort of eyes and nose |
|
| Scientific Title | A study for the effects of ingestion of
yogurt in adults with discomfort of eyes and nose :A randomized, double-blind, placebo controlled trial |
|
| Scientific Title:Acronym | A study for the effects of ingestion of
yogurt in adults with discomfort of eyes and nose |
|
| Region |
|
|
| Condition | ||
| Condition | Healthy adults | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | This study aims to evaluate the effects of ingestion of yogurt on the subjective evaluation of the discomfort of eyes and nose, and blood index |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Questionnaire of discomfort of eyes and nose,Diary.
Evaluate at points of 12-week and 4-week, 8-week |
| Key secondary outcomes | Specific IgE(RAST), IFN-Gamma, IL-13, Total IgE(RIST)
|
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Ingestion of yogurt drink containing lactic acid bacteria LH strain for 12 consecutive weeks | |
| Interventions/Control_2 | Ingestion of yogurt drink without lactic acid bacteria LH strain for 12 consecutive weeks | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | (1)Subjects aged from 20 to 64 years old
(2)Subjects with discomfort of eyes and nose(sneeze,runny nose, nasal) (3)Subjects positive for specific IgE(RAST)against house dust or mite. (4)Subjects who are judged as healthy adult for the study by the investigator |
|||
| Key exclusion criteria | (1)Subjects who routinely take foods or medicines containing of lactic acid bacteria.
(2)Subjects who routinely take foods or medicines affecting the test result (3)Subjects who have history of regular visits of otorhinolaryngology or planned to clinic visits (4)Subjects who has received a diagnosis of seasonal allergic rhinitis (pollen allergy) (5)Subjects with acute rhinitis, sinusitis or hypertrophic rhinitis (6)Subjects with bronchial asthma (7)Subjects who are under treatment or have a history of serious disease(e.g., diabetes, liver disease, kidney disease, or heart disease) (8)Subjects who are under medication(e.g., hyposensitization)which may influence the outcome of the study (9)Subjects with allergies to the test food in the study (10)Subjects judged as unsuitable for the study by the investigator for laboratory evidence or cardiopulmonary function (11)Subjects who have a disease requiring regular medication or a history of serious diseases for which medication was required (12)Subjects who are judged as unsuitable for the study based on the results of clinical and physical examination on preliminary examination (13)Subjects who have participated in other clinical study within the last one month prior to the current study or are planned to participate in other clinical study after informed consent for the current study (14)Subjects who are planned to become pregnant after informed consent for the current study or are pregnant or lactating (15)Subjects who are judges as unsuitable for the study based on the results of lifestyle questionnaire (16)Subjects who are judged as unsuitable for the study by the investigator for other reason |
|||
| Target sample size | 100 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | MEGMILK SNOW BRAND Co.,Ltd. | ||||||
| Division name | Milk Science Research Institute. Food Function Laboratory | ||||||
| Zip code | |||||||
| Address | 1-1-2 Minamidai,Kawagoe,Saitama,Japan | ||||||
| TEL | 049-242-8111 | ||||||
| tfujita@meg-snow.com | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | TTC Co., Ltd. | ||||||
| Division name | Clinical Research Planning Department | ||||||
| Zip code | |||||||
| Address | 1-20-2, Ebisunishi, Shibuya-ku, Tokyo | ||||||
| TEL | 03-5459-5329 | ||||||
| Homepage URL | |||||||
| c.goto@ttc-tokyo.co.jp | |||||||
| Sponsor | |
| Institute | TTC Co., Ltd. |
| Institute | |
| Department | |
| Funding Source | |
| Organization | MEGMILK SNOW BRAND Co.,Ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031843 |